tirzepatide for psoriatic arthritis π¨ First-of-its-kind Phase 3b data: treating obesity improves outcomes Today, Eli Lilly and Company announced positive topline results from TOGETHER-PsA, the first controlled trial evaluating an incretin therapy used alongside TOGETHER-PsA:Tirzepatide + Ixekizumab Rapidly Improves
Pay in 4 interest-free payments of $6.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 17 - Aug 22

















:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)







